Segment Covered
The report on global ophthalmic drugs market covers segments such as, disease condition and dispenses type. On the basis of disease
condition the global ophthalmic drugs market is categorized into allergy, glaucoma, dry eye disorder and retinal disorder. On the basis
of dispense type the global ophthalmic drugs market is categorized into prescription and over the counter.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2015-2023.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan,
India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the
European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific
region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region
is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
Companies Profiled:
The report provides profiles of the companies in the global ophthalmic drugs market such as, Abbott Healthcare, Allergan Plc, Johnson
& Johnson, Bayer, Valeant Pharmaceuticals, Inc., Pfizer, Inc., Merck & Co., Novartis AG, Renegeron and Santen Pharmaceuticals
Company Ltd.
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report
provides insights on the factors that are driving and restraining the global ophthalmic drugs market. Moreover, IGR-Growth Matrix
analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of ophthalmic drugs
market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future
trends in the ophthalmic drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis
given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers,